AMGN compared with TARS: revenue, margins and what each company keeps, and the suppliers and customers both name

AMGNAmgen Inc

Mkt capRevenueRevenue

TARSTarsus Pharmaceuticals, Inc.

Mkt capRevenueRevenue

Compare

AMGNAmgen Inc

TARSTarsus Pharmaceuticals, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

AMGN

4 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±3.7%▲+3.73%×1.00

Q2 FY26±4.1%▲+4.57%×1.12

Q1 FY26±3.9%▼−4.75%×1.23

Feb 4 '26±3.7%▲+8.15%×2.22

TARS

0 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26thin chain±12.8%▼−4.91%×0.38

Q2 FY26±10.5%▲+6.59%×0.63

= impliedAMGN realized, solidTARS realized, hatchedOne scale, both sides: full bar = 15%× = |realized| ÷ impliedSource: market data

Q1 FY26±13.4%▼−1.24%×0.09

Feb 24 '26±14.8%▲+7.79%×0.53

AMGNAmgen Inc

460.55▲+0.06%· post 460.42

Mkt cap$249.0BRevenue$10.4BQ3 FY26Revenue$36.8BFY25

TARSTarsus Pharmaceuticals, Inc.

68.43▲+1.35%· post 69.59

ClosedNov 6 '26

Mkt cap$3.4BRevenue$195MQ3 FY26Revenue$451MFY25

Compare

ClosedNov 6 '26

AMGNAmgen Inc

TARSTarsus Pharmaceuticals, Inc.

460.55▲+0.06%post 460.42

Price

68.43▲+1.35%post 69.59

$249.0B

Mkt cap

$3.4B

Q3 FY26$10.4B

Revenue

$195MQ3 FY26

FY25$36.8B

Revenue

$451MFY25

AMGN460.55▲+0.06%vsTARS68.43▲+1.35%ClosedNov 6 '26